Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 5 clinical trials
TAB014 Compared to Lucentis® in Patients With Neovascular Age-related Macular Degeneration (nAMD)

This study is a randomized, multi-center, double blind, Lucentis controlled non-inferiority study in neovascular age-related macular degeneration patients. The objective of this study is to

  • 0 views
  • 04 Oct, 2022
  • 1 location
Phase I Study to Compare CMAB818 Injection and Lucentis® in Patients With Wet AMD

This is a randomized, double-blind, two-group parallel, positive-controlled clinical Phase I trial comparing the safety, pharmacokinetics, pharmacodynamics and efficacy of CMAB818 and Lucentis®

  • 0 views
  • 05 Jul, 2022
  • 1 location
  • 0 views
  • 07 Oct, 2022
  • 1 location
A Study to Evaluate the Efficacy and Safety of MW02 in the Treatment of nAMD

The purpose of this study is to compare the efficacy and safety of MW02 versus Lucentis in the treatment of neovascular age-related macular degeneration.The study was divided into two stages

  • 0 views
  • 10 Apr, 2022
  • 1 location
Regulatory Post-Marketing Surveillance(PMS) Study for Lucentis®(Ranibizumab) in Patients With Retinopathy of Prematurity

This study is an open-labeled, multicenter, single arm, observational post-marketing surveillance study under routine clinical practice with no mandated treatments, visits or assessments.

  • 0 views
  • 17 Oct, 2022
  • 1 location